Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

142.78
Delayed Data
As of Jun 26
 -1.71 / -1.18%
Today’s Change
95.14
Today|||52-Week Range
147.45
+26.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line7.4M113.7M38.1M52.1M
 
 
 
 
 
Depreciation2.5M2.8M3.3M6.2M
 
 
 
 
 
Total Other Cash Flow13.3M18.7M28.7M25.7M
 
 
 
 
 
Funds From Operations24.0M48.0M92.4M109.8M
 
 
 
 
 
Funds From/For Other Operating Expenses530.0K4.7M15.6M-5.3M
 
 
 
 
 
Net Cash Flow - Operating Activities23.5M43.3M76.8M115.1M
 
 
 
 
 
 
InvestingIncrease In Investments-87.8M-100.5M-261.7M-281.4M
 
 
 
 
 
Decrease In Investments68.3M71.5M219.6M205.5M
 
 
 
 
 
Capital Expenditures-2.8M-5.2M-15.6M-50.4M
 
 
 
 
 
Net Assets From Acquisitions 0.00-15.7M0.000.00
 
 
Net Cash Flow Investing-22.3M-49.9M-57.7M-126.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00-446.0K
 
 
Net Proceeds Stock Sale10.1M11.7M10.9M12.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--606.0K3.6M12.0M
 
 
 
 
Other Uses - Financing425.0K2.8M7.3M20.1M
 
 
 
 
 
Net Cash Flow - Financing9.6M9.5M7.2M3.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash639.0K-1.5M-415.0K-1.8M
 
 
 
 
 
 
Net Change In Cash10.8M3.0M26.2M-7.4M